WELCOME TO THE
ICPO FOUNDATION
The International Centers for Precision Oncology Foundation (ICPO) is a nonprofit organization established in 2019 under German law by leading international medical practitioners and life sciences entrepreneurs.
Cancer is one of the most significant health challenges of our time and the need for more effective treatments is pressing. Recognizing a paradigm shift in cancer care from one size fits all to a personalized approach, the ICPO Foundation´s aim is to gain momentum for Radiotheranostics in cancer care worldwide and scale global patient access to this innovative therapy. Radiomolecular Precision Oncology is a highly targeted therapy with low side effects, improved efficacy and patient outcomes.
The ICPO Foundation is establishing an international collaborative network of accredited ICPO Theranostics Centers of Excellence by sharing knowledge, standards and education in Radiomolecular Precision Oncology. World-class standardized education of healthcare professionals is key to ensure sustainable patient access at a global scale. Therefore, the ICPO Foundation launched the ICPO Academy for Theranostics.
The goals of the ICPO Foundation
- Scaling global patient access to Radiomolecular Precision Oncology
- Supporting theranostics education and research
- Building the ICPO Collaborating Centers network
- Creating a collaborative theranostics community
Online Event: ICPO Virtual Theranostics Summit 2026 Date: Nov 12-13, 2026
Format: Virtual conference with international experts from academia and industry in the field of theranostics in precision oncology.
After a very successful 2nd edition in 2024 with over 400 participants, the ICPO Foundation is delighted to announce its next ICPO Theranostics Virtual Summit in 2026 – a must-attend online event gathering hundreds of international healthcare professionals passionate about Theranostics!
The virtual event will feature renowned international experts from the ICPO Community who will present on the latest innovations, clinical insights, and patient-centered advances in Theranostics, and with whom you will be able to interact online.
The ICPO Summit will be uniquely chaired by a trio of exceptions, namely:
- Prof. Richard P. Baum, Trustee of ICPO Foundation, President of ICPO Academy for Theranostics and Theranostics Lead Physician at Curanosticum, Wiesbaden-Frankfurt, Germany,
- Prof. Frederik L. Giesel, Head of Nuclear Medicine at University Clinic Düsseldorf, Germany
- Prof. Rudolf A. Werner, Head of Nuclear Medicine at University Clinic LMU, Munich, Germany.
Pre-registration: Please send an e-mail to Susanne Simon, Head of Communications: susanne.simon@icpo.foundation
As soon as the registration platform is online, we will send you an email with the details for your final registration.
Sponsoring the ICPO Virtual Theranostics Summit2026 offers your organization a meaningful opportunity to engage with a highly specialized international audience, contribute to the advancement of education and collaboration in Theranostics, and support an event that plays an important role leading the future of the field.
To receive information about the various sponsorship packages, please contact Juan Davila, Partner Engagement & Fundraising Director at juan.davila@icpo.foundation.
4th ICPO Forum 2025 on 15 & 16, 2025 near Munich on TUM campus: Advancing Theranostics in Precision Oncology
Over 220 experts from 27 countries came together to shape the future of radiotheranostics for better cancer patient outcomes. This biannual conference brought together a broad spectrum of stakeholders – from academia, industry, patient advocacy groups and professional associations to investors and philanthropists. Forty international experts shared their insights on the global evolution of theranostics, latest advancements in education and accreditation, the growth of the ICPO Theranostics Centers network, as well as radiopharmaceuticals game changers and the role of artificial intelligence (AI).
